HEART and TIMI Scores Predict Severe Coronary Atherosclerosis in Patients With End-Stage Renal Disease

Trishna B Parikh1, Moez Aziz1, Samuel P Mackoff1

  • 1Internal Medicine, University of Texas, John P and Kathrine G McGovern School of Medicine, Houston, USA.

Cureus
|July 17, 2023
PubMed

Insights

The HEART and TIMI risk scores effectively predict severe coronary artery disease in patients with end-stage renal disease (ESRD). These scores offer valuable risk stratification for this high-risk population, similar to their use in the general population.

Area of Science:

  • Cardiology
  • Nephrology
  • Diagnostic Accuracy

Background:

  • History, EKG, age, risk factors, and troponin (HEART) and thrombolysis in myocardial infarction (TIMI) risk scores are validated for predicting acute coronary syndromes and severe coronary atherosclerosis.
  • The performance of these scores in patients with end-stage renal disease (ESRD), a population with a high pretest probability for coronary artery disease, is not well-established.

Purpose of the Study:

  • To determine if HEART and TIMI risk scores can predict severe coronary atherosclerosis in patients with end-stage renal disease (ESRD).

Main Methods:

  • Retrospective cohort study of 231 admitted ESRD patients on dialysis who underwent coronary angiography.
  • HEART and TIMI scores were calculated at presentation and compared with coronary angiography outcomes.
  • Receiver operating characteristic and logistic regression analyses were used to determine optimal score cutoffs and associations.

Main Results:

  • Mean HEART score was 6±2 and mean TIMI score was 3±1.
  • Optimal cutoffs for severe coronary lesions were 6-7 for HEART (AUC=0.754) and 3-4 for TIMI (AUC=0.716).
  • Diabetes mellitus, age ≥65, and angina pectoris were associated with severe coronary artery disease (CAD).

Conclusions:

  • HEART and TIMI risk scores are useful in predicting severe coronary atherosclerosis in the complex ESRD population.
  • These scores demonstrate similar predictive performance in ESRD patients as in the general population.

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
42
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
10
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
465
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
13
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
35